Contents of this document
- Developed a new medium-term management plan for 2026–2030
- Designated O&M, next-generation geothermal power, critical minerals, pharmaceuticals and advanced materials as priority areas
- Expand the business scope from EPC to the entire plant life cycle
- Signed an MOU for the 2nd phase of the large-scale gas-chemical complex renovation project in Turkmenistan
- Won EPC contracts in India for a polypropylene project for BPCL and an ammonium nitrate plant project for GNFC
- Established a Global Digital Operations Center in India
- Orders received¥1,758 100 million
- Orders received, including equity-method investments¥4,204 100 million
- ROE-28.9 %
- PBR3.5 times
- PER-10.2 times
- EPS¥-255.03
- BPS¥742.79
- Employee Engagement3.8 Out of 5Year on year against the same period last yearImproved from the previous score of 3.58
- Lost-time injury frequency rate0.11 Cases per 1 million actual working hours
- Fertilizer demand: 3.07% annual growth through 2033
- Global ethylene market: 5.7% compound annual growth rate
- India's biopharmaceutical market: 8% CAGR
- Japan's next-generation geothermal power-generation capacity: 2–3 GW in 2040 and 7.7 GW in 2050
- Indonesia's geothermal power-generation capacity: target to add approximately 5 GW by 2034
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026, full-year results |
| Net Sales | ¥1,829 100 million |
| Operating profit | ¥-190 100 million |
| Ordinary income | ¥-113 100 million |
| Net income | ¥-149 100 million |
| Gross Profit Margin | 3.5 % |
| Selling, general and administrative expenses | ¥254 100 million |
| Full-year earnings forecast | Net Sales ¥1,900 100 million / Gross profit ¥280 100 million / Gross Profit Margin 14.7 % / Operating profit ¥30 100 million / Ordinary income ¥75 100 million / Net income ¥60 100 million / Orders received ¥2,000 100 million / Dividends 25 Per share, year-end |
| Self-assessment against the plan | Orders exceeded the full-year forecast at the end of the fiscal year. Net income was in line with the full-year forecast announced on 12 February. |
| Key KPIs | Indicator name Orders received / Value ¥1,758 100 million / Year on year against the same period last year Not disclosed, Indicator name Orders received, including equity-method investments / Value ¥4,204 100 million / Year on year against the same period last year Not disclosed, Indicator name ROE / Value -28.9 % / Year on year against the same period last year Not disclosed, Indicator name PBR / Value 3.5 times / Year on year against the same period last year Not disclosed, Indicator name PER / Value -10.2 times / Year on year against the same period last year Not disclosed, Indicator name EPS / Value ¥-255.03 / Year on year against the same period last year Not disclosed, Indicator name BPS / Value ¥742.79 / Year on year against the same period last year Not disclosed, Indicator name Employee Engagement / Value 3.8 Out of 5 / Year on year against the same period last year Improved from the previous score of 3.58, Indicator name Lost-time injury frequency rate / Value 0.11 Cases per 1 million actual working hours / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees Approximately 6,000 people (group total); approximately 120 personnel currently engaged in new technology and business development at Toyo-J / Changes during the period and hiring plan Not disclosed |
| Assumptions Underlying the Business Outlook | Exchange rate ¥150/US dollar |
| Medium-term management plan targets | New Medium-Term Management Plan Consolidated net income of ¥10.0 billion in 2030 / Flow-type and stock-type mix Chart showing a 40% stock-type and 60% flow-type mix in 2030 |
| Financial targets | ROE Target Consistently above 10% / Actual results for the fiscal year ending March 2026 -28.9 / Fiscal year ending March 2027 (forecast) 12.9 |
| Annual Dividend | Fiscal year ending March 2026 ¥0 / Fiscal year ending March 2027 Year-end dividend of ¥25 planned / Interim and Year-End Breakdown Interim: not disclosed; year-end: ¥25 planned |
| Orders received and order backlog | Orders received ¥1,758 100 million / Orders received, including equity-method investments ¥4,204 100 million / Order backlog Not disclosed |
| Market Size / Share | Fertilizer demand: 3.07% annual growth through 2033, Global ethylene market: 5.7% compound annual growth rate, India's biopharmaceutical market: 8% CAGR, Japan's next-generation geothermal power-generation capacity: 2–3 GW in 2040 and 7.7 GW in 2050, Indonesia's geothermal power-generation capacity: target to add approximately 5 GW by 2034 |
| New initiatives | Developed a new medium-term management plan for 2026–2030, Designated O&M, next-generation geothermal power, critical minerals, pharmaceuticals and advanced materials as priority areas, Expand the business scope from EPC to the entire plant life cycle, Signed an MOU for the 2nd phase of the large-scale gas-chemical complex renovation project in Turkmenistan, Won EPC contracts in India for a polypropylene project for BPCL and an ammonium nitrate plant project for GNFC, Established a Global Digital Operations Center in India |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The main causes of the loss were the emergence of collection risks on receivables from the Brazil power-generation project, as well as schedule delays and higher costs resulting from unexpected equipment problems and other factors. For the fiscal year ending March 2027, the Company expects to execute projects reliably through the elimination of unprofitable projects and the implementation of measures to improve profitability.